Cabot Turnaround Letter Weekly Update
Today’s note includes earnings updates and the podcast.
Read More
HEAR Archives
Cabot Prime Pro Week Ending April 16, 2021
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Prime Week Ending April 16, 2021
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Early Opportunities Special Bulletin
We’ve seen a big improvement in the way many growth and early-stage stocks are acting over the last two weeks. Many of our stocks that sold off in March have been gaining some altitude back, and many of those that were acting well to...
Read More
Cabot Explorer 733
Markets seem to be pausing a bit, with some stocks losing momentum while a few show surprising strength.
Read More
Cabot Small-Cap Confidential Weekly Update
It’s been another mostly constructive week as many of our stocks inch higher and the economic picture continues to improve.
Read More
Cabot Income Advisor Weekly Update
This is an incredible market that just keeps creeping higher. The promise of a booming recovery with trillions in stimulus ahead continues to pull stocks to new all-time highs.
Read More
Cabot Growth Investor Bi-weekly Update
Continue to go slow but have your shopping list ready. Growth stocks are gradually improving their standing, with more popping toward their highs, many holding their gains and a few finding some good-volume buying.
Read More
Cabot Marijuana Investor Update
Nine weeks ago, as the marijuana sector was completing what looked like a climax top, I took the risky step of taking partial profits in ten of our stocks, moving to a 45% cash position.
Read More
Cabot Dividend Investor 421
This is an unusual environment to say the least. The market is looking ahead to the highest GDP growth in decades as vaccines end the lockdowns and restrictions. And forecasts continue to rise. At the same time, trillions in government stimulus will flood the...
Read More
Cabot Undervalued Stocks Advisor Weekly Update
EBITDA, or earnings before interest, taxes, depreciation and amortization, is a straight-forward measure (not a perfect measure, though) of a company’s cash operating profits. But, like seemingly all metrics published by company managements, it is usually adjusted for unusual items that may be non-recurring.
Read More
Cabot Profit Booster 170
This Friday is the expiration of our six April Covered Call positions. I would categorize these six positions as a good, but somewhat mixed bag, as only one trade looks like it will expire for its full profit potential (ANF), while four (TRIP, SUM, AMKR, AZEK) in...
Read More
Cabot Stock of the Week 343
The leading indexes continue to hit record highs, telling us the bull market that began over a year ago, though it is showing some signs of age, remains intact.
Read More
Cabot Turnaround Letter Weekly Update
Today’s note includes earnings updates and the podcast.
Read More
Cabot Prime Week Ending April 9, 2021
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Prime Pro Week Ending April 9, 2021
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Growth Investor 1469
Sellers Fading—but Will the Buyers Show Up?
We’re all about going with the evidence, and when it comes to growth stocks, the evidence was nearly uniformly negative (or at least not positive) for most of the past month. The vast majority of leading stocks, many...
Read More
Cabot Small-Cap Confidential Weekly Update
There’s no doubt things are looking a little better out there as many software, MedTech and other growth stocks retested their March lows late last week then turned north. The timing of that short-term reversal, coinciding with the end of the first quarter, definitely...
Read More
Cabot Global Stocks Explorer Bi-weekly Update
Nearly 95% of companies in the S&P 500 are now trading above their 200-day moving average, according to Dow Jones Market Data, the highest percentage since May 2013. As if we didn’t have enough to worry about, as of late February, investors had a..
Read More
What is EBITDA and Why Do We Use It?
You probably hear the term EBITDA get tossed around a lot by investment analysts. But exactly what is EBITDA, and why is it useful?
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up